株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

CountryFocus:ブラジルの医療・規制・医療費償還制度の状況

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil

発行 GlobalData 商品コード 287369
出版日 ページ情報 英文 199 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.53円で換算しております。
Back to Top
CountryFocus:ブラジルの医療・規制・医療費償還制度の状況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil
出版日: 2017年06月09日 ページ情報: 英文 199 Pages
概要

当レポートでは、ブラジルの医療関連市場の動向や、医療費償還制度およびその他の関連規制・制度について分析し、医薬品産業・医療装置産業の全体的構造・動向、医療費償還制度やその周辺の保険市場の動向、医療規制当局の構造や各種規制の概要、ブラジル経済・社会に関するマクロ的指標(医療インフラなど)といった情報を取りまとめています。

第1章 目次

第2章 イントロダクション

第3章 医薬品・医療機器市場の概要

  • 医薬品市場
    • 市場概況
    • 医薬品の輸出入
    • 供給経路
    • 市場の分類
    • 主な疾患分野
    • 主要企業
  • 医療機器市場
    • 市場概況
    • 上位5分野の概況
    • 診断市場
    • 主要企業
  • 市場の促進・阻害要因
    • 促進要因
    • 阻害要因

第4章 市場へのアクセス

  • 医療制度の概要
    • 組織構造
  • 医療費償還・保険料支払者の状況
    • 医療費償還の過程
    • 薬価制定の手順
    • 保険業者の概要
    • 医療費支出に対する患者負担の比率
    • 処方薬の価格動向
    • 薬価政策
  • 規制環境
    • 規制機関の概要
    • 新薬の認証過程
    • ジェネリック医薬品の認証過程
    • 医療機器新製品の認証過程
    • 医薬品・医療機器の製造認可過程
    • 医薬品の輸出・輸入の認可
    • 知的所有権
    • 治験関連の規制
    • 医薬品の広告に関する規制
    • 薬局関連の規制
    • ラベリング・包装に関する規制

第5章 国の分析

  • 政治環境
  • 経済環境
  • 経済指標
  • 人口統計
  • 医療インフラ
    • 医療施設
    • 医療関連パラメーター
    • 環境問題
    • 医療従事者
  • 医療費支出
    • 概要
    • 医療費支出の主な要素
    • 公共/民間部門のシェア
    • 医薬品の研究開発(R&D)活動への支出額
  • 業界団体
  • 展示会

第6章 市場機会と課題

  • 市場機会
  • 課題

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC0081CHR

Brazil has one of the fastest growing pharmaceutical markets in the world. It is driven by an increasing disease burden and high affordability. However, a decrease in foreign investment and increased government promotion of generic drugs are barriers to growth. The value of the market was US$25.3 Billion in 2016, having increased from US$15.4 Billion in 2009 at a Compound Annual Growth Rate (CAGR) of 3.4%. Changing demographics are an important driver for the market, as the increasingly elderly population will lead to an increase in the incidence of chronic and other lifestyle-associated diseases. The growing middle class, who have high purchasing power, is another major driver.

Brazil's medical device market was valued at US$7.1 Billion in 2009 and US$9.7 Billion in 2016. It is projected to grow at a CAGR of 6.4% from US$10.9 Billion in 2017 to US$14 Billion in 2021. In 2016, In Vitro Diagnostics (IVD) accounted for 11.5% of the medical device market, followed by orthopedic devices (10.8%), diagnostic imaging (10.6%), ophthalmic devices (8.8%) and cardiovascular devices (8.7%).

Most hospitals in Brazil offer primary care services exclusively. In 2016, health expenditure accounted for 8.2% of GDP, having accounted for 8.6% in 2009. Brazilian hospitals have inadequate resources and are thereby unable to provide access to healthcare provisions for every citizen, especially to those in weaker economic sections.

Brazil entered a period of recession in 2015. The economy contracted by 3.6% in 2016. This was due to a fall in commodity prices and political instability that led to a decline in investor confidence. This was augmented by the Chinese economic slowdown, which led to reduced demand for commodities and the corruption scandals involving government officials and major companies. In August 2016, following mass nationwide protests, President Rousseff was impeached on charges of breaking budgetary laws and the incumbent vice president Michel Temer took over.

The report "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil" an overview of the pharmaceutical and medical device market of Brazil, including the market size; market segmentation by generic, Over-The-Counter (OTC), biologic and biosimilar products; and the key drivers and barriers for the market.

In depth, this report provides the following analysis -

  • Covers the country's reimbursement and payer landscape, as well as the regulatory landscape. The reimbursement and payer landscape section elaborates on the features of the healthcare reimbursement process for Brazil.
  • Provides a detailed analysis of the political and economic environment of Brazil. It analyzes its economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
  • Provides an overview of the opportunities and challenges for growth that exist in the healthcare market of Brazil.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Brazil, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Hypermarcas, Roche, Novartis and Sanofi and Profiles and SWOT analyses of the major players in the medical device market: Johnson & Johnson, B.Braun, Medtronic, Baxter and GSK.
  • An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country's political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Brazil healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Brazil's healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Brazil's healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 6

2 Executive Summary 8

3 Introduction 12

  • 3.1 GlobalData Report Guidance 12

4 Overview of Pharmaceutical and Medical Device Markets 13

  • 4.1 Pharmaceutical Market 13
    • 4.1.1 Market Overview 13
    • 4.1.2 Pharmaceutical Exports and Imports 15
    • 4.1.3 Supply Channels 16
    • 4.1.4 Market Segments 18
    • 4.1.5 Overview of Top Five Disease Areas 21
    • 4.1.6 Major Players 23
  • 4.2 Medical Device Market 53
    • 4.2.1 Market Overview 53
    • 4.2.2 Overview of Top Five Segments 55
    • 4.2.3 Diagnostic Market 66
    • 4.2.4 Major Players 67
  • 4.3 Market Drivers and Barriers 96
    • 4.3.1 Drivers 96
    • 4.3.2 Barriers 97

5 Market Access 99

  • 5.1 Overview of Healthcare system 99
  • 5.2 Reimbursement and Payer Landscape 100
  • 5.3 Reimbursement Process 101
    • 5.3.1 Overview of Insurance Providers 102
    • 5.3.2 Patient Share in Healthcare Expenditure 105
    • 5.3.3 Price Trends in the Healthcare Sector 106
    • 5.3.4 Pricing Policies 106
  • 5.4 Regulatory Landscape 109
    • 5.4.1 Overview of Regulatory Agencies 109
    • 5.4.2 Market Authorization Procedure for Pharmaceutical Products 114
    • 5.4.3 New Medical Device Approval Process 116
    • 5.4.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 119
    • 5.4.5 Intellectual Property Rights 120
    • 5.4.6 Clinical Trial Regulations 124
    • 5.4.7 Pharmaceutical Advertising Regulations 124
    • 5.4.8 Pharmacy Regulations 125
    • 5.4.9 Labeling and Packaging Regulations 126

6 Country Analysis 127

  • 6.1 Political Environment 127
    • 6.1.1 Political Structure 127
    • 6.1.2 Current Political Environment 128
    • 6.1.3 Healthcare Policy Initiatives 129
  • 6.2 Economic Landscape 130
  • 6.3 Economic Indicators 132
    • 6.3.1 Gross Domestic Product 132
    • 6.3.2 Gross National Income 136
    • 6.3.3 Inflation 137
    • 6.3.4 Currency Exchange Rate 140
    • 6.3.5 Foreign Direct Investment 141
    • 6.3.6 Foreign Exchange Reserves 142
    • 6.3.7 Trade Balance 143
    • 6.3.8 Government Structural Balance 145
    • 6.3.9 Government Net Debt 146
    • 6.3.10 Major Industries 148
  • 6.4 Demographics 149
    • 6.4.1 Population 149
  • 6.5 Healthcare Infrastructure 168
    • 6.5.1 Healthcare Facilities 168
    • 6.5.2 Healthcare Parameters 171
    • 6.5.3 Environmental Health 173
  • 6.6 Healthcare Expenditure 175
    • 6.6.1 Overview 175
    • 6.6.2 Share of Public and Private Sectors 176
    • 6.6.3 Major Components of Healthcare Expenditure 177
    • 6.6.4 Spending in Pharmaceutical R&D 178
  • 6.7 Trade Associations 179
    • 6.7.1 ABIMO 179
    • 6.7.2 ABIMED 179
    • 6.7.3 Interfarma 179
    • 6.7.4 Abiquifi 180
  • 6.8 Trade Fairs 180

7 Opportunities and Challenges 181

  • 7.1 Opportunities 181
  • 7.2 Challenges 181

8 Appendix 183

  • 8.1 Abbreviations 183
  • 8.2 Bibliography 188
  • 8.3 Research Methodology 197
    • 8.3.1 Coverage 197
    • 8.3.2 Secondary Research 197
    • 8.3.3 Forecasts 198
    • 8.3.4 Expert Panel 198
  • 8.4 Contact Us 198
  • 8.5 Disclaimer 199

List of Tables

1.1 List of Tables

  • Table 1: Pharmaceutical Market, Brazil, Revenue ($bn), 2009-2016 14
  • Table 2: Pharmaceutical Market, Brazil, Revenue ($bn), 2017-2021 15
  • Table 3: Pharmaceutical Market, Brazil, Exports and Imports ($bn), 2009-2016 16
  • Table 4: Pharmaceutical Market, Brazil, Generic Market ($bn), 2009-2016 18
  • Table 5: Pharmaceutical Market, Brazil, Mortality by Major Disease Areas (%), 2014 21
  • Table 6: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2017 24
  • Table 7: Pharmaceutical Market, Roche, Global, Revenue ($m) and Annual Growth (%) of Major Products, 2016 34
  • Table 8: Pharmaceutical Market, Roche, Global, Late-stage Pipeline, 2017 35
  • Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016 41
  • Table 10: Pharmaceutical Market, Novartis, Planned Filings, 2017-2020 41
  • Table 11: Sanofi, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016 48
  • Table 12: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2017 49
  • Table 13: Medical Device Market, Brazil, Revenue ($bn), 2009-2016 53
  • Table 14: Medical Device Market, Brazil, Revenue ($bn), 2017-2021 54
  • Table 15: Medical Device Market, Brazil, Revenue ($m) and Market Share (%) by Segment, 2016 55
  • Table 16: In Vitro Diagnostics Market, Brazil, Revenue ($bn), 2009-2016 56
  • Table 17: In Vitro Diagnostics, Brazil, Revenue ($m) and Market Share (%) of Major Players, 2014 57
  • Table 18: Orthopedic Device Market, Brazil, Revenue ($bn), 2009-2016 58
  • Table 19: Orthopedic Devices, Brazil, Revenue ($m) and Market Share (%) of Major Players, 2015 59
  • Table 20: Diagnostic Imaging Market, Brazil, Revenue ($bn), 2009-2016 60
  • Table 21: Diagnostic Imaging, Brazil, Revenue ($m) and Market Share (%) of Major Players, 2015 61
  • Table 22: Ophthalmic Device Market, Brazil, Revenue ($m), 2009-2016 62
  • Table 23: Ophthalmic Device Market, Brazil, Revenue ($m) and Market Share (%) of Major Players, 2015 63
  • Table 24: Cardiovascular Device Market, Brazil, Revenue ($m), 2009-2016 64
  • Table 25: Cardiovascular Device Market, Brazil, Revenue ($m) and Market Share (%) of Major Players, 2016 65
  • Table 26: Cardiovascular Device Market, Brazil, Revenue ($m), 2009-2016 66
  • Table 27: Diagnostic Market, Brazil, Revenue ($m), 2017-2021 67
  • Table 28: Major Players, Brazil, Revenue ($m), 2012 68
  • Table 29: Medical Device Market, Medtronic, Major Products, 2016 80
  • Table 30: Baxter, Global, Major Products, 2016 86
  • Table 31: Healthcare System, Brazil, 2016 99
  • Table 32: Healthcare Expenditure, Brazil, Out-of-Pocket Expenditure (%), 2009-2016 105
  • Table 33: Market Access, Brazil, Price Change (%), 2009-2016 106
  • Table 34: Pricing Policies, Brazil, 2016 107
  • Table 35: Market Access, Brazil, Compensation Services for Patents ($), 2014 123
  • Table 36: Market Access, Brazil, Compensation Services for Trademarks ($), 2014 124
  • Table 37: Economic Indicators, Brazil, GDP per Capita ($), 2009-2016 132
  • Table 38: Economic Indicators, Brazil, GDP per Capita ($), 2017-2021 133
  • Table 39: Economic Indicators, Brazil, GDP Annual Growth (%), 2009-2016 134
  • Table 40: Economic Indicators, Brazil, GDP Annual Growth (%), 2017-2021 135
  • Table 41: Economic Indicators, Brazil, GNI per Capita ($), 2009-2016 136
  • Table 42: Economic Indicators, Brazil, Consumer Price Index, 2009-2016 137
  • Table 43: Economic Indicators, Brazil, Average Consumer Price Index Annual Change (%), 2009-2016 138
  • Table 44: Economic Indicators, Brazil, Average Consumer Price Index, Annual Change (%), 2017-2021 139
  • Table 45: Economic Indicators, Brazil, Currency Exchange Rate ($/BRL), 2009-2016 140
  • Table 46: Economic Indicators, Brazil, Foreign Direct Investment ($bn), 2009-2016 141
  • Table 47: Economic Indicators, Brazil, Foreign Exchange Reserves ($bn), 2009-2016 142
  • Table 48: Economic Indicators, Brazil, Imports of Goods and Services ($bn), 2009-2016 143
  • Table 49: Economic Indicators, Brazil, Exports of Goods and Services ($bn), 2009-2016 144
  • Table 50: Economic Indicators, Brazil, General Government Structural Balance ($bn), 2009-2016 145
  • Table 51: Economic Indicators, Brazil, Government Net Debt ($bn), 2009-2016 146
  • Table 52: Economic Indicators, Brazil, Government Net Debt ($bn), 2017-2021 147
  • Table 53: Economic Indicators, Brazil, Production Index of Major Industries (physical production), 2017 148
  • Table 54: Demographics, Brazil, Population (million), 2009-2016 149
  • Table 55: Demographics, Brazil, Population (million), 2017-2021 150
  • Table 56: Demographics, Brazil, Urban-Rural Population Share (%), 2009-2016 151
  • Table 57: Demographics, Brazil, Urban-Rural Population Share (%), 2017-2021 152
  • Table 58: Demographics, Brazil, Population Distribution by Age Group (%), 2009-2016 153
  • Table 59: Demographics, Brazil, Population Distribution by Age Group (%), 2017-2021 154
  • Table 60: Demographics, Brazil, Births (per 1,000 population), 2009-2016 155
  • Table 61: Demographics, Brazil, Mortality (per 1,000 Population), 2009-2016 156
  • Table 62: Demographics, Brazil, Major Causes of Mortality (per 100,000 population), 2014 157
  • Table 63: Demographics, Brazil, Mortality Rate of Children Under Five (per 1,000 live births), 2009-2016 158
  • Table 64: Demographics, Brazil, Immunization Rate (%), 2009-2016 159
  • Table 65: Demographics, Brazil, Major Causes of Male Mortality (per 100,000 population), 2014 160
  • Table 66: Demographics, Brazil, Major Causes of Female Mortality (per 100,000 population), 2014 161
  • Table 67: Demographics, Brazil, Gender Ratio (M/F), 2009-2016 162
  • Table 68: Demographics, Brazil, Life Expectancy at Birth (years), 2009-2016 163
  • Table 69: Demographics, Brazil, Life Expectancy at Birth (years), 2017-2021 164
  • Table 70: Demographics, Brazil, Gross Enrollment Ratio (%), 2009-2016 165
  • Table 71: Demographics, Brazil, Unemployment Rate (%), 2009-2016 166
  • Table 72: Demographics, Brazil, Disability-Adjusted Life Years by Major Disease ('000), 2012 167
  • Table 73: Healthcare Infrastructure, Brazil, Hospital Types (%), 2015 168
  • Table 74: Healthcare Infrastructure, Brazil, Hospital Beds, 2009-2016 169
  • Table 75: Healthcare Infrastructure, Brazil, Diagnostic Units (per 1,000,000 population), 2009-2016 170
  • Table 76: Healthcare Infrastructure, Brazil, Hospitals Beds (per 1,000 population), 2009-2016 171
  • Table 77: Healthcare Infrastructure, Brazil, Doctors (per 1,000 population), 2009-2016 172
  • Table 78: Healthcare Infrastructure, Brazil, PM2.5 (µg per m³), 2009-2016 173
  • Table 79: Healthcare Infrastructure, Brazil, CO2 Emissions (metric tons per capita), 2009-2016 174
  • Table 80: Healthcare Infrastructure, Brazil, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 175
  • Table 81: Healthcare Infrastructure, Brazil, Public-Private Share of Expenditure (%), 2009-2016 176
  • Table 82: Healthcare Infrastructure, Brazil, Major Components of Healthcare Expenditure (%), 2013 177
  • Table 83: Healthcare Infrastructure, Brazil, Share of R&D Expenditure (%), 2013 178
  • Table 84: Healthcare Expenditure, Brazil, Major Healthcare Trade Fairs, 2017 180

List of Figures

1.2 List of Figures

  • Figure 1: Pharmaceutical Market, Brazil, Revenue ($bn), 2009-2021 8
  • Figure 2: Medical Device Market, Brazil, Revenue ($bn), 2009-2021 9
  • Figure 3: Country Profile, Brazil, 2017 11
  • Figure 4: Pharmaceutical Market, Brazil, Revenue ($bn), 2009-2016 14
  • Figure 5: Pharmaceutical Market, Brazil, Revenue ($bn), 2017-2021 15
  • Figure 6: Pharmaceutical Market, Brazil, Exports and Imports ($bn), 2009-2016 16
  • Figure 7: Pharmaceutical Market, Brazil, Distribution Channels, 2016 17
  • Figure 8: Pharmaceutical Market, Brazil, Generic Market ($bn), 2009-2016 18
  • Figure 9: Pharmaceutical Market, Brazil, Mortality by Major Disease Areas (%), 2014 21
  • Figure 10: Medical Device Market, Brazil, Revenue ($bn), 2009-2016 53
  • Figure 11: Medical Device Market, Brazil, Revenue ($bn), 2017-2021 54
  • Figure 12: Medical Device Market, Brazil, Revenue by Segment ($bn), 2016 55
  • Figure 13: In Vitro Diagnostics Market, Brazil, Revenue ($bn), 2009-2016 56
  • Figure 14: In Vitro Diagnostics, Brazil, Market Share of Major Players (%), 2014 57
  • Figure 15: Orthopedic Device Market, Brazil, Revenue ($bn), 2009-2016 58
  • Figure 16: Orthopedic Device Market, Brazil, Market Share of Major Players (%), 2016 59
  • Figure 17: Diagnostic Imaging Market, Brazil, Revenue ($bn), 2009-2016 60
  • Figure 18: Diagnostic Imaging, Brazil, Market Share of Major Players (%), 2015 61
  • Figure 19: Ophthalmic Device Market, Brazil, Revenue ($m), 2009-2016 62
  • Figure 20: Ophthalmic Device Market, Brazil, Market Share of Major Players (%), 2015 63
  • Figure 21: Cardiovascular Device Market, Brazil, Revenue ($m), 2009-2016 64
  • Figure 22: Cardiovascular Device Market, Brazil, Market Share of Major Players (%), 2016 65
  • Figure 23: Diagnostic Market, Brazil, Revenue ($m), 2009-2016 66
  • Figure 24: Diagnostic Market, Brazil, Revenue ($m), 2017-2021 67
  • Figure 25: Major Players, Brazil, Revenue ($m), 2012 68
  • Figure 26: Healthcare Market, Brazil, Drivers and Barriers, 2017 98
  • Figure 27: Market Access, Brazil, Reimbursement Process, 2014 102
  • Figure 28: Healthcare Expenditure, Brazil, Out-of-Pocket Expenditure (%), 2009-2016 105
  • Figure 29: Market Access, Brazil, Price Change (%), 2009-2016 106
  • Figure 30: Healthcare System, Brazil, Flowchart for Classification of Drugs into Categories, 2014 109
  • Figure 31: Market Access, Brazil, Ministry of Health Structure, 2016 111
  • Figure 32: Market Access, Brazil, Drug Approval Process, 2016 115
  • Figure 33: Economic Indicators, Brazil, GDP per Capita ($), 2009-2016 132
  • Figure 34: Economic Indicators, Brazil, GDP per Capita ($), 2017-2021 133
  • Figure 35: Economic Indicators, Brazil, GDP Annual Growth (%), 2009-2016 134
  • Figure 36: Economic Indicators, Brazil, GDP Annual Growth (%), 2017-2021 135
  • Figure 37: Economic Indicators, Brazil, GNI per Capita ($), 2009-2016 136
  • Figure 38: Economic Indicators, Brazil, Consumer Price Index, 2009-2016 137
  • Figure 39: Economic Indicators, Brazil, Average Consumer Price Index, Annual Change (%), 2009-2016 138
  • Figure 40: Economic Indicators, Brazil, Average Consumer Price Index, Annual Change (%), 2017-2021 139
  • Figure 41: Economic Indicators, Brazil, Currency Exchange Rate ($/BRL), 2009-2016 140
  • Figure 42: Economic Indicators, Brazil, Foreign Direct Investment ($bn), 2009-2016 141
  • Figure 43: Economic Indicators, Brazil, Foreign Exchange Reserves ($bn), 2009-2016 142
  • Figure 44: Economic Indicators, Brazil, Imports of Goods and Services ($bn), 2009-2016 143
  • Figure 45: Economic Indicators, Brazil, Exports of Goods and Services ($bn), 2009-2016 144
  • Figure 46: Economic Indicators, Brazil, Government Structural Balance ($bn), 2009-2016 145
  • Figure 47: Economic Indicators, Brazil, Government Net Debt ($bn), 2009-2016 146
  • Figure 48: Economic Indicators, Brazil, Government Net Debt ($bn), 2017-2021 147
  • Figure 49: Economic Indicators, Brazil, Production Index of Major Industries (physical production), 2017 148
  • Figure 50: Demographics, Brazil, Population (million), 2009-2016 149
  • Figure 51: Demographics, Brazil, Population (million), 2017-2021 150
  • Figure 52: Demographics, Brazil, Urban-Rural Population Share (%), 2009-2016 151
  • Figure 53: Demographics, Brazil, Urban-Rural Population Share (%), 2017-2021 152
  • Figure 54: Demographics, Brazil, Population Distribution by Age Group (%), 2009-2016 153
  • Figure 55: Demographics, Brazil, Population Distribution by Age Group (%), 2017-2021 154
  • Figure 56: Demographics, Brazil, Births (per 1,000 population), 2009-2016 155
  • Figure 57: Demographics, Brazil, Mortality (per 1,000 Population), 2009-2016 156
  • Figure 58: Demographics, Brazil, Major Causes of Mortality (per 100,000 population), 2014 157
  • Figure 59: Demographics, Brazil, Mortality Rate of Children Under Five (per 1,000 live births), 2009-2016 158
  • Figure 60: Demographics, Brazil, Immunization Rate (%), 2009-2016 159
  • Figure 61: Demographics, Brazil, Major Causes of Male Mortality (per 100,000 population), 2014 160
  • Figure 62: Demographics, Brazil, Major Causes of Female Mortality (per 100,000 population), 2014 161
  • Figure 63: Demographics, Brazil, Gender Ratio (M/F), 2009-2016 162
  • Figure 64: Demographics, Brazil, Life Expectancy at Birth (years), 2009-2016 163
  • Figure 65: Demographics, Brazil, Life Expectancy at Birth (years), 2017-2021 164
  • Figure 66: Demographics, Brazil, Gross Enrollment Ratio (%), 2009-2016 165
  • Figure 67: Demographics, Brazil, Unemployment Rate (%), 2009-2016 166
  • Figure 68: Demographics, Brazil, Major Diseases, Disability-Adjusted Life Years by Major Disease ('000s), 2012 167
  • Figure 69: Healthcare Infrastructure, Brazil, Hospital Types (%), 2015 168
  • Figure 70: Healthcare Infrastructure, Brazil, Hospital Beds, 2009-2016 169
  • Figure 71: Healthcare Infrastructure, Brazil, Diagnostic Units (per 1,000,000 population), 2009-2016 170
  • Figure 72: Healthcare Infrastructure, Brazil, Hospitals Beds (per 1,000 population), 2009-2016 171
  • Figure 73: Healthcare Infrastructure, Brazil, Doctors (per 1,000 population), 2009-2016 172
  • Figure 74: Healthcare Infrastructure, Brazil, PM2.5 (µg per m³), 2009-2016 173
  • Figure 75: Healthcare Infrastructure, Brazil, CO2 Emissions (metric tons per capita), 2009-2016 174
  • Figure 76: Healthcare Infrastructure, Brazil, Healthcare Expenditure as Percentage of GDP (%), 2009-2016 175
  • Figure 77: Healthcare Infrastructure, Brazil, Public-Private Share of Expenditure (%), 2009-2016 176
  • Figure 78: Healthcare Infrastructure, Brazil, Major Components of Healthcare Expenditure (%), 2013 177
  • Figure 79: Healthcare Infrastructure, Brazil, Share of R&D Expenditure (%), 2013 178
  • Figure 80: Healthcare Market, Brazil, Opportunities and Challenges, 2017 182
Back to Top